NOVOZYMES A/S/S (OTCMKTS:NVZMY) is scheduled to announce its earnings results on Thursday, August 8th. Analysts expect the company to announce earnings of $0.53 per share for the quarter.
Shares of NVZMY stock opened at $45.45 on Wednesday. NOVOZYMES A/S/S has a 12 month low of $40.38 and a 12 month high of $55.84. The stock’s fifty day moving average price is $46.76. The company has a current ratio of 1.22, a quick ratio of 0.71 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $13.50 billion, a P/E ratio of 25.97, a P/E/G ratio of 2.10 and a beta of 0.70.
Separately, Zacks Investment Research downgraded shares of NOVOZYMES A/S/S from a “hold” rating to a “sell” rating in a research report on Tuesday, July 30th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $54.00.
Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. The company offers agriculture solutions, including crop protection, and animal health and nutrition solutions; fermentation, lignecellulosic hydrolysis, liquefaction, process enhancement, and saccharifaction solutions for bioenergy; baking, beverages, dairy, and protein ingredients for the food and beverage industry; and laundry, dishwashing, hand washing, and cleaning solutions for the household care industry.
Read More: What is a Tariff?
Receive News & Ratings for NOVOZYMES A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NOVOZYMES A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.